Organisation · GOV.UK transparency returns · American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications
American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications
- Identity
organisation:govuk:American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications— the GOV.UK transparency returns key, used as-is. No identity here is invented.- Graph built
- 5 September 2026
Names in the records
Each spelling a register uses for this entity, and the method that tied it here. A name is never the identity; a similar name is never a match.
| As published | Register | Tied by | Confidence | Rows |
|---|---|---|---|---|
| American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications | GOV.UK transparency returns | exact name within one register | 1.0 | 1 |
What the records establish
- American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications: 1 record of "recorded meeting with a minister" on 23 June 2022.
| Relationship | With | Date | Amount | Detail | Record |
|---|---|---|---|---|---|
| recorded meeting with a minister | Lord Kamall | 23 June 2022 | — | ministerial_meetings |
What this does not establish
The records above establish that American Pharmaceutical Group (APG); Amgen UK & Ireland; BMS UK & Ireland; AbbVie UK; Lilly UK, Ireland, and Northern European Hub; Vertex UK & Ireland; Biogen UK & Ireland; Gilead UK & Ireland; Janssen UK & Ireland; Merck Sharp Dohme; Hanover Communications and each entity named appear together in an official register, in the relationship that register records, on the date it records. They do not establish why any donation was made, why any contract was awarded, whether any one record was known to the people behind another, or that any record caused another. No causal inference is made on this page, and nothing here is a finding of any kind against anyone. A reported donation is a lawful, reported transaction; a contract award is a published notice; a seat is a seat.
Derived from: ministerial_meetings. Each row above names the table and key it came from and links the official record where one exists. How the graph is built is described at the evidence graph.